ArticleIsrael journal of health policy research2026
Maintaining ambulatory care capacity through telemedicine during wartime: insights from a tertiary center's experience.
Article in Israel journal of health policy research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA state of war has the potential to profoundly disrupt routine, essential ambulatory hospital services, negatively impacting both acute hospitalizations and continuity of care. During June 2025, a war ignited between Israel and Iran, causing multiple casualties and substantial damage to essential healthcare facilities. This study examined the impact of the war on ambulatory visit volumes at Israel's largest tertiary medical center and assessed the contribution of telemedicine encounters to mitigating conflict-related disruptions.
methodsThis is a retrospective analysis of ambulatory service data collected at Sheba Tel HaShomer Medical Center between June 13 and June 24, 2025, compared to the corresponding period in the previous years (2021-2024), with a focus on the methodologies and managerial decisions implemented. We conducted an interrupted time series analysis using annual outpatient data from matched dates in 2021-2025. We modeled the proportion of visits delivered via telemedicine using segmented linear regression, incorporating calendar year as a continuous time variable and an indicator marking the onset of the 2025 regional war to estimate the immediate change in telemedicine use, adjusted for pre-war trends.
resultsBetween June 13 and 24, 2025, Sheba Medical Center conducted 53,158 ambulatory visits, of which 9,478 (17.8%) were via telemedicine. Half of the patients were male, and 47.8% were aged 25-64 years. From 2021 to 2024, telemedicine use increased gradually from 2.5% to 5.0% of visits. In 2025, utilization rose sharply following the Israel-Iran conflict. Interrupted time series analysis estimated a pre-war annual increase of 0.86 percentage points, with a 12.2 percentage point level change during the war (95% CI 9.0-15.5). Compared with 2024, total visits declined 20.0%, in-person visits fell 30.8%, and telemedicine visits increased 182.9%. The largest telemedicine growth occurred in cardiovascular (463.6%), pediatric (434.4%), and neurology/neurosurgery (350.5%) divisions, while pediatrics and psychiatry had the highest proportions of remote visits (40.2% and 33.9%, respectively).
conclusionsA robust telemedicine infrastructure and well-established operational methodologies developed during peacetime may enable the continuity of ambulatory services during wartime. The rapid expansion of telemedicine capacity helped minimize the overall reduction in healthcare services available to the community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.